PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

PostEraPfizerPartner

More Like This

PR Newswire associated0

PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

Debiopharm to Reveal Insights From Their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at the 2025 AACR Conference in Chicago

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

PR Newswire associated0

XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

GlobeNewswire associated0

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

PR Newswire associated0

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program